Your browser doesn't support javascript.
loading
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
Park, H; Shapiro, G I; Gao, X; Mahipal, A; Starr, J; Furqan, M; Singh, P; Ahrorov, A; Gandhi, L; Ghosh, A; Hickman, D; Gallacher, P D; Wennborg, A; Attar, E C; Awad, M M; Das, S; Dumbrava, E E.
Afiliación
  • Park H; Division of Oncology, Alvin J Siteman Cancer Center, Washington University, St. Louis, USA. Electronic address: haeseongpark@wustl.edu.
  • Shapiro GI; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.
  • Gao X; Massachusetts General Hospital Cancer Center, Boston, USA.
  • Mahipal A; Division of Medical Oncology, Department of Oncology, Mayo Clinic Cancer Center, Rochester, USA.
  • Starr J; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Jacksonville, USA.
  • Furqan M; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA.
  • Singh P; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Phoenix, USA.
  • Ahrorov A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gandhi L; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.
  • Ghosh A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Hickman D; Aprea Therapeutics, Boston, USA.
  • Gallacher PD; Aprea Therapeutics, Boston, USA.
  • Wennborg A; Aprea Therapeutics, Boston, USA.
  • Attar EC; Aprea Therapeutics, Boston, USA.
  • Awad MM; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.
  • Das S; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA.
  • Dumbrava EE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.
ESMO Open ; 7(5): 100573, 2022 10.
Article en En | MEDLINE | ID: mdl-36084396
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido